How to Value a Naturopathic Medicine Practice in 2026

Naturopathic medicine is one of the fastest-growing practice segments I see in healthcare M&A, and it's also one of the most inconsistently valued. The reason is that naturopathic practices are really three businesses bolted together: a clinical consultation practice, a retail supplement business, and a lab testing referral business. Each of those has different margins, different durability, and different multiples — and if a seller or a buyer doesn't break them apart, somebody leaves a lot of money on the table.

Most naturopathic practices I've valued trade between 2.0x and 4.0x SDE, with the majority clustering around 2.5-3.5x. Here's what moves you up or down in that range.

The Naturopathic Valuation Range

• 1.5-2.0x SDE: Solo ND, cash-pay, no supplement dispensary, patient base built entirely on the doctor's personal brand. Hard to sell.
• 2.5-3.0x SDE: Solo or small-group practice with a functioning supplement dispensary (Fullscript, Emerson, Wellevate) contributing 20-30% of revenue, some recurring patients, reasonable systems.
• 3.0-3.5x SDE: Multi-provider practice with a real dispensary, documented lab testing workflows, membership or package revenue, documented clinical protocols.
• 3.5-4.0x+ SDE: Multi-location or specialty-focused (hormones, gut health, oncology support) with a strong associate ND bench and high-margin lab/supplement revenue exceeding 40% of total collections.

The wide range reflects how differently two naturopathic practices can be structured. A $900K revenue practice with 70% clinical visits and 30% supplements has very different economics than a $900K practice with 45% clinical, 35% supplements, and 20% specialty lab testing markup.

Supplement Revenue: Margin Is the Story

Supplement dispensing is the single highest-margin line in most naturopathic practices, and how you structure it directly drives your valuation. There are three common models and they get valued very differently.

In-house retail inventory. The practice purchases supplements wholesale (typically 50-55% of MSRP through direct accounts with Designs for Health, Thorne, Pure Encapsulations, Standard Process, Integrative Therapeutics) and sells at or near MSRP. Gross margin of 45-50% on retail supplements. This model gets the highest valuation weight because it behaves like a real retail business — a buyer can see inventory, understand margin, and project revenue.

Online dispensary (Fullscript, Wellevate, Emerson). The practice recommends supplements through a platform that drop-ships to the patient and pays the practice a margin of typically 20-40% of list price. Lower margin than in-house, but zero inventory risk and zero cash tied up. Buyers like this model because the revenue data is pristine — every transaction is tracked in the platform and can be exported as a data room file.

Referral-only with no margin. The ND recommends supplements and the patient buys them wherever they want. Zero supplement revenue. This is the weakest position valuation-wise because the practice is leaving obvious money on the table — and buyers will calculate what the practice could have earned and price it as if you'd captured that revenue.

If your dispensary is generating $180K-$350K annually at 35-45% gross margin on a $900K revenue practice, that's $65K-$155K of high-margin contribution that flows directly to SDE. Break it out on your P&L. Buyers will apply the overall SDE multiple to it, but they'll pay more attention if you can show them a clean revenue-and-margin trend over 36 months.

Lab Partnerships and Specialty Testing

Specialty lab testing is the quietly valuable part of most naturopathic practices. Tests like DUTCH (hormone), GI-MAP (stool), Organic Acids (OAT), food sensitivity panels, and heavy metals panels are typically billed through the practice with a markup of 20-50% over the lab's direct-to-provider price.

A practice ordering 12-20 specialty panels per week at an average markup of $80-$150 per test is generating $50K-$160K of high-margin lab revenue annually. More importantly, specialty testing drives supplement sales and repeat visits — the test reveals something, the ND creates a protocol, the patient buys supplements and comes back in 90 days to retest. That's a durable revenue cycle buyers are willing to pay for.

When preparing for sale, document:

• Number of specialty panels ordered per month
• Average markup per test category
• Retest rate (what percentage of patients repeat a panel within 12 months)
• Attached supplement revenue per protocol

Practices that can show this data get a meaningfully better valuation than those that just report "lab revenue" as an undifferentiated P&L line.

Licensure and Scope: The State-by-State Reality

Naturopathic medicine is only fully licensed in about 25 states, plus DC and the US territories. In licensed states (Oregon, Washington, California, Arizona, Colorado, Connecticut, and others), NDs can order labs, prescribe within a formulary, and bill insurance. In unlicensed states, the scope is much narrower and the practice economics look more like a health coaching business.

This matters enormously for valuation. A licensed-state practice can trade at 3-4x SDE because the scope is clear, the liability is insurable, and the buyer pool includes other NDs who can maintain scope. An unlicensed-state practice often trades at 1.5-2.5x SDE because the buyer is limited to someone willing to operate within the narrower scope, and there's always regulatory overhang.

If you're in a licensed state, emphasize your prescriptive authority, lab ordering authority, and insurance credentialing in your offering memo. These are real assets that don't show up on a balance sheet but materially affect what a buyer will pay.

Cash-Pay Versus Insurance

Most naturopathic practices are 70-100% cash-pay, which is actually good news for valuation. Cash revenue is cleaner, there's no AR risk, and there's no payer compliance exposure in diligence.

Typical naturopathic visit fees:

• Initial 90-minute consultation: $325-$600
• 45-minute follow-up: $175-$325
• 15-minute check-in: $75-$150
• Specialty protocols (IV therapy, hormone pellets): $150-$500 per visit

A well-run ND solo practice sees 12-18 patients per day at an average visit value of $225-$325 (blending initials, follow-ups, and same-day supplement sales). That generates $650K-$1.2M of collections on a full schedule. The practices that maintain those visit values without discounting, and who have documented protocols that produce patient outcomes, command the higher end of the multiple range.

What Kills Naturopathic Practice Value

Founder-led personal brand. Same problem as acupuncture and chiropractic. If patients follow you on Instagram and come for you specifically, the practice is worth 30-40% less than an identical one with brand-level loyalty.

No associate ND. Solo practices cap out around 2.5-3x SDE. Having an associate ND seeing 30%+ of patient volume is worth 0.5-0.8x on your multiple.

Muddy P&L. Mixing clinical, supplement, lab, and personal expenses into one undifferentiated P&L is the fastest way to get discounted in diligence. Buyers can't tell what's real, and they assume the worst.

Compounded prescription dependence. Practices heavily reliant on compounding pharmacy relationships (BHRT, low-dose naltrexone, peptides) are exposed to FDA enforcement cycles that can shut off revenue streams overnight. Buyers discount that revenue 20-40%.

How to Maximize Your Exit

Convert as much supplement revenue as possible to an in-house or online dispensary model with documented transaction data. Revenue you can prove is worth more than revenue you claim.

Break your P&L into clinical visits, dispensary, lab markup, and any ancillary services (IV, injections, body composition). Three years of clean, segmented financials changes the diligence conversation entirely.

Hire an associate ND at least 18 months before sale. Even part-time. Prove the clinical model works with a different face.

Develop specialty positioning. A generalist naturopathic practice competes with every other ND in town. A practice positioned around hormone health, gut restoration, or integrative oncology has defensible differentiation that buyers will pay for. The 18-month pre-sale preparation timeline I use with medical practice sellers applies almost directly to naturopathic practices — the levers are the same, the timing is the same, and the outcomes improve the same way.

The Bottom Line

Naturopathic practice valuation rewards sellers who treat their practice like a multi-line business and penalizes those who treat it like a clinical job. The difference between a 2.2x SDE exit and a 3.5x SDE exit on a $900K revenue practice is roughly $350K of sale price — and that difference is almost entirely driven by whether you documented your dispensary and lab economics, built a non-founder brand, and brought in an associate. None of that is clinical work. It's the business work most NDs wish they'd started earlier.